Short communication: Normal tissue injury after cancer therapy is a local response exacerbated by an endocrine effect of TGFβ

M. S. Anscher, Feng Ming Kong, T. Murase, R. L. Jirtle

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

The sensitivity of normal tissues rather than of the tumour usually limits the effectiveness of cancer treatment. The normal tissue side effects from chemotherapy and/or radiotherapy result from both direct cellular loss and the extensive fibrosis that develops at the site of injury. Recent evidence suggests that the cytokine, transforming growth factor β (TGFβ), mediates this fibrogenic process. Herein, we provide evidence in support of the hypothesis that the fibrosis formation following therapy results not only from TGFβ produced locally in the injured normal tissue, but also from circulating TGFβ released by the tumour. Thus, therapy-induced normal tissue damage appears in part to be a local manifestation of a systemic condition.

Original languageEnglish (US)
Pages (from-to)331-333
Number of pages3
JournalBritish Journal of Radiology
Volume68
Issue number807
DOIs
StatePublished - Jan 1 1995

Fingerprint

Transforming Growth Factors
Wounds and Injuries
Neoplasms
Fibrosis
Therapeutics
Radiotherapy
Cytokines
Drug Therapy

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Short communication : Normal tissue injury after cancer therapy is a local response exacerbated by an endocrine effect of TGFβ. / Anscher, M. S.; Kong, Feng Ming; Murase, T.; Jirtle, R. L.

In: British Journal of Radiology, Vol. 68, No. 807, 01.01.1995, p. 331-333.

Research output: Contribution to journalArticle

Anscher, M. S. ; Kong, Feng Ming ; Murase, T. ; Jirtle, R. L. / Short communication : Normal tissue injury after cancer therapy is a local response exacerbated by an endocrine effect of TGFβ. In: British Journal of Radiology. 1995 ; Vol. 68, No. 807. pp. 331-333.
@article{9094e3bb8d89446b97e8678394b2b71f,
title = "Short communication: Normal tissue injury after cancer therapy is a local response exacerbated by an endocrine effect of TGFβ",
abstract = "The sensitivity of normal tissues rather than of the tumour usually limits the effectiveness of cancer treatment. The normal tissue side effects from chemotherapy and/or radiotherapy result from both direct cellular loss and the extensive fibrosis that develops at the site of injury. Recent evidence suggests that the cytokine, transforming growth factor β (TGFβ), mediates this fibrogenic process. Herein, we provide evidence in support of the hypothesis that the fibrosis formation following therapy results not only from TGFβ produced locally in the injured normal tissue, but also from circulating TGFβ released by the tumour. Thus, therapy-induced normal tissue damage appears in part to be a local manifestation of a systemic condition.",
author = "Anscher, {M. S.} and Kong, {Feng Ming} and T. Murase and Jirtle, {R. L.}",
year = "1995",
month = "1",
day = "1",
doi = "10.1259/0007-1285-68-807-331",
language = "English (US)",
volume = "68",
pages = "331--333",
journal = "British Journal of Radiology",
issn = "0007-1285",
publisher = "British Institute of Radiology",
number = "807",

}

TY - JOUR

T1 - Short communication

T2 - Normal tissue injury after cancer therapy is a local response exacerbated by an endocrine effect of TGFβ

AU - Anscher, M. S.

AU - Kong, Feng Ming

AU - Murase, T.

AU - Jirtle, R. L.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - The sensitivity of normal tissues rather than of the tumour usually limits the effectiveness of cancer treatment. The normal tissue side effects from chemotherapy and/or radiotherapy result from both direct cellular loss and the extensive fibrosis that develops at the site of injury. Recent evidence suggests that the cytokine, transforming growth factor β (TGFβ), mediates this fibrogenic process. Herein, we provide evidence in support of the hypothesis that the fibrosis formation following therapy results not only from TGFβ produced locally in the injured normal tissue, but also from circulating TGFβ released by the tumour. Thus, therapy-induced normal tissue damage appears in part to be a local manifestation of a systemic condition.

AB - The sensitivity of normal tissues rather than of the tumour usually limits the effectiveness of cancer treatment. The normal tissue side effects from chemotherapy and/or radiotherapy result from both direct cellular loss and the extensive fibrosis that develops at the site of injury. Recent evidence suggests that the cytokine, transforming growth factor β (TGFβ), mediates this fibrogenic process. Herein, we provide evidence in support of the hypothesis that the fibrosis formation following therapy results not only from TGFβ produced locally in the injured normal tissue, but also from circulating TGFβ released by the tumour. Thus, therapy-induced normal tissue damage appears in part to be a local manifestation of a systemic condition.

UR - http://www.scopus.com/inward/record.url?scp=0028923805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028923805&partnerID=8YFLogxK

U2 - 10.1259/0007-1285-68-807-331

DO - 10.1259/0007-1285-68-807-331

M3 - Article

C2 - 7735779

AN - SCOPUS:0028923805

VL - 68

SP - 331

EP - 333

JO - British Journal of Radiology

JF - British Journal of Radiology

SN - 0007-1285

IS - 807

ER -